Three Drugs Could Make Up Half Of Forecasted Psychedelic Sales By 2029
The psychedelic drug market is projected to soar to $7.2 billion by 2029, reflecting a 55% compound annual growth rate (CAGR) and further showing its power.
Kevin Marcaida Us Drug Enforcement Agency Atai Life Sciences Otsuka Pharmaceutical Drug Administration Atai Life Otsuka Pharmaceutical
Source: forbes.com